Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Design of novel Magnetic Graphene Oxide Nanozyme platform for Theranostic applications

Descripción del proyecto

Plataforma híbrida para inducir la muerte de las células cancerosas

Centrarse en los mecanismos subyacentes a la muerte de las células cancerosas es fundamental para producir materiales multifuncionales eficaces para aplicaciones oncológicas. El objetivo del proyecto MagGraphZyme, financiado por las Acciones Marie Skłodowska-Curie, es desarrollar una plataforma híbrida para activar la producción intracelular de especies reactivas del oxígeno/nitrógeno (ERO/ERN), que se utilizarán para provocar la muerte de las células cancerosas. A fin de mejorar la producción de ERO/ERN, la plataforma propuesta se basará en nanopartículas magnéticas, óxidos de grafeno decorados con nitrógeno y una cubierta polimérica (PLGA). Además, se estudiarán determinadas rutas de señalización para comprender mejor las diferentes rutas celulares implicadas en la toxicidad y muerte de las células.

Objetivo

MagGraphZyme aims at the development of a new hybrid multiplatform capable of triggering the intracellular production of reactive oxygen/nitrogen species (ROS/RNS) for inducing cell death in cancer cells. The proposed hybrid nanosystem, based on the combination of magnetic nanoparticles (MNPs), nitrogen doped graphene oxide (N-GO) and a polymer (PLGA) shell, will improve ROS/RNS production due to the synergistic effects of all components regarding their catalytic activity as peroxidase-mimetic nanozymes. The control of this catalytic activity will be performed by heating the intracellular level via the activation of the constituent MNPs through a remotely applied magnetic field. Thus, a novel approach for intracellular ROS/RNS production and quantification will be implemented. Furthermore, with the aim of understanding the different cells’ pathways involved in the toxicity and the final death of the cells, these hybrid system will be evaluated to investigate pathway-specific ROS/RNS induction of apoptosis and ROS-response mechanisms. Thus, I will study signaling pathways which are known to be influenced by the production of these species. To this end, I propose detailed physical and chemical studies, down to the atomic level, of the MNPs@N-GO-PLGA systems for identifying the relationships between catalytic efficacy and active atomic sites within the structures. These works will be developed by a motivated researcher with a strong background in MNPs, who will enhance and diversify his skills in advanced microscopy techniques and will acquire competences in bio-medicine. This multidisciplinary and innovative proposal will strengthen the collaboration between the hosting institutions, will enable the European hosting institution to reinforce crucial competences in the understanding & production of multifunctional materials and will contribute to improving oncological applications, which is one of the most important scientific challenges with a high social impact.

Régimen de financiación

MSCA-PF - MSCA-PF

Coordinador

UNIVERSIDAD DE ZARAGOZA
Aportación neta de la UEn
€ 261 380,64
Dirección
CALLE PEDRO CERBUNA 12
50009 Zaragoza
España

Ver en el mapa

Región
Noreste Aragón Zaragoza
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos

Socios (1)